Kinesia’s HomeView™ and ProView™ technologies provide standardized platforms to quantify Parkinson’s disease symptoms in the clinic and at home. The Kinesia patient kit and web application provide continuous remote symptom monitoring and reporting. Applications include patient care via telemedicine, clinical trials, and deep brain stimulation programming.
We have partnered with world-renowned movement disorder centers, thought leaders and neurologists to conduct clinical studies validating Kinesia automated scoring algorithms to quantify tremor, measure bradykinesia, and assess dyskinesia. Hundreds of individuals with Parkinson’s disease have successfully used Kinesia for assessing movement disorders in both clinical and home environments.
We were recently awarded 4 patents in the last 8 months, including claims that cover controlling Parkinson’s therapy such as deep brain stimulation or drug release in response to symptoms. A publication was also recently accepted that compares sensitivity of Kinesia technology to clinician scoring of Parkinson’s for very small changes in symptoms.